Advanced Search
Contact | Corporate | Help

Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme

Sponsors:
  • Duke University
  • Genentech
  • OSI Pharmaceuticals
Phases:
  • Phase II
IndicationsAcronym:
  • Glioblastoma
  • Gliosarcoma
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Erlotinib, Sirolimus
Enrollment:
20

Additional information about NCT00672243.


SourceSolution © 2008-2012